logo

Homology Medicines, Inc. (FIXX)



Trade FIXX now with
  Date
  Headline
7/21/2020 8:06:17 AM Homology Medicines Names Jeff Poulton To Board
10/21/2019 8:36:48 AM Homology Medicines Presents Data From PKU And MLD Gene Therapy Programs
7/15/2019 4:38:36 PM Homology Medicines Appoints Alise Reicin To Board Of Directors
6/10/2019 8:34:35 AM Homology Medicines Initiates Phase 1/2 Study For HMI-102 Gene Therapy Candidate For Adults With PKU
5/14/2019 9:10:12 AM Homology Medicines Announces FDA Fast Track Designation For HMI-102 Gene Therapy Development Candidate
4/9/2019 9:13:53 PM Homology Medicines Prices Underwritten Public Offering Of 5.56 Mln Shares At $22.50/shr
4/4/2019 7:04:30 AM Homology Medicines Announces FDA Clearance Of IND Application For HMI-102 Gene Therapy Candidate For PKU
1/7/2019 9:26:42 AM Homology Medicines Says It Achieved All Corporate Goals For 2018
10/18/2018 7:17:15 AM Homology Medicines Presents Long-Term Efficacy Data Of Single Dose Of Gene Therapy Development Candidate
8/13/2018 4:18:43 PM Homology Medicines Q2 Loss/share $0.35 Vs. Loss $2.61 Year Ago
5/14/2018 4:36:05 PM Homology Medicines Q1 Loss/share $4.21 Vs. Loss $2.79 Year Ago